CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

News Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE Other stock markets 04:00:03 2026-07-31 pm EDT			5-day change	1st Jan Change
232.51 ^USD	-0.90%		+1.40%	+16.56%

Jul. 29	Align Technology to add directors, launch review after deal with Elliott	RE
Jul. 20	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…

All News

Mentions Relevance

Jul. 15	Charles River Laboratories Schedules Second-Quarter 2026 Earnings Release and Conference Call	BU
Jul. 13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT
Jul. 13	Baird Adjusts Charles River Laboratories International Price Target to $255 From $213, Maintains Outperform Rating	MT
Jul. 13	Charles River Laboratories to Provide Cell Sequencing Services to Arovella Therapeutics	MT
Jul. 13	Charles River Provides Ngs Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches	CI
Jul. 13	Mizuho Adjusts Price Target on Charles River Laboratories International to $230 From $192, Maintains Neutral Rating	MT
Jul. 13	Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches	BU
Jul. 09	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
Jul. 07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
Jul. 03	Did Charles River Laboratories International, Inc. Insiders Breach their Fiduciary Duties to Shareholders?	PR
Jul. 01	Charles River Laboratories International Insider Sold Shares Worth $16,875,000, According to a Recent SEC Filing	MT
Jul. 01	Argus Raises Price Target on Charles River Laboratories International to $250 From $200, Maintains Buy Rating	MT
Jun. 18	Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise	BU
Jun. 18	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT
Jun. 17	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT
Jun. 17	Morgan Stanley Upgrades Charles River Laboratories International to Overweight From Equal Weight, Adjusts PT to $220 From $185	MT
Jun. 05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
Jun. 03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM
Jun. 02	Charles River Laboratories International, Inc. Presents at 46th Annual William Blair Growth Stock Conference, Jun-02-2026 10:00 AM
Jun. 01	Charles River Laboratories to Present at William Blair and Jefferies Conferences	BU
May. 13	Charles River Laboratories, Medipost Sign MoU on GMP-Compliant Testing	MT
May. 13	Charles River Laboratories and Medipost sign non-exclusive MoU to advance GMP testing solutions	RE
May. 13	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions	BU
May. 11	Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors	CI
May. 11	Charles River Laboratories International, Inc. Announces Board Elections	CI